{{Rsnum
|rsid=1569788
|Gene=ESR1
|Chromosome=6
|position=152007481
|Orientation=plus
|GMAF=0.4132
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ESR1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.1 | 36.3 | 56.6
| HCB | 25.6 | 48.1 | 26.3
| JPT | 25.7 | 51.3 | 23.0
| YRI | 36.5 | 47.6 | 15.9
| ASW | 23.6 | 58.2 | 18.2
| CHB | 25.6 | 48.1 | 26.3
| CHD | 30.8 | 47.7 | 21.5
| GIH | 25.7 | 42.6 | 31.7
| LWK | 43.9 | 48.6 | 7.5
| MEX | 5.3 | 21.1 | 73.7
| MKK | 38.6 | 43.1 | 18.3
| TSI | 8.8 | 29.4 | 61.8
| HapMapRevision=28
}}{{PMID|18305958|OA=1
}} 577 African American individuals with T2DM-ESRD and 596 AA controls.
*[[rs1569788]] (nominal P = 0.000754, adjusted P = 0.0278)

{{PMID Auto
|PMID=20797716
|Title=Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure
}}

{{PMID Auto
|PMID=18654799
|Title=Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}